Clinical Trial Update: Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo [Phase 1]

View source ↗

Summary

A Phase 1 trial update reports the hemodynamic responses to a sublingual dose of glyceryl trinitrate in participants also receiving TA-1790, sildenafil citrate,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Glyceryl Trinitrate (sublingual) (glyceryl trinitrate)
• Sildenafil citrate (Sildenafil citrate)
• TA-1790

Snippet

Sponsor: VIVUS LLC | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED